Life Stem Genetics Inc.; Order of Suspension of Trading, 71021 [2013-28607]

Download as PDF Federal Register / Vol. 78, No. 229 / Wednesday, November 27, 2013 / Notices At any time within 60 days of the filing of such proposed rule change, the Commission summarily may temporarily suspend such rule change if it appears to the Commission that such action is necessary or appropriate in the public interest, for the protection of investors, or otherwise in furtherance of the purposes of the Act. If the Commission takes such action, the Commission shall institute proceedings under Section 19(b)(2)(B) 23 of the Act to determine whether the proposed rule change should be approved or disapproved. IV. Solicitation of Comments Interested persons are invited to submit written data, views, and arguments concerning the foregoing, including whether the proposed rule change is consistent with the Act. Comments may be submitted by any of the following methods: emcdonald on DSK67QTVN1PROD with NOTICES Electronic Comments • Use the Commission’s Internet comment form (http://www.sec.gov/ rules/sro.shtml); or • Send an email to rule-comments@ sec.gov. Please include File Number SR– NASDAQ–2013–140 on the subject line. Paper Comments • Send paper comments in triplicate to Elizabeth M. Murphy, Secretary, Securities and Exchange Commission, 100 F Street NE., Washington, DC 20549–1090. All submissions should refer to File Number SR–NASDAQ–2013–140. This file number should be included on the subject line if email is used. To help the Commission process and review your comments more efficiently, please use only one method. The Commission will post all comments on the Commission’s Internet Web site (http://www.sec.gov/ rules/sro.shtml). Copies of the submission, all subsequent amendments, all written statements with respect to the proposed rule change that are filed with the Commission, and all written communications relating to the proposed rule change between the Commission and any person, other than those that may be withheld from the public in accordance with the provisions of 5 U.S.C. 552, will be available for Web site viewing and printing in the Commission’s Public Reference Room, 100 F Street NE., Washington, DC 20549, on official business days between the hours of 10:00 a.m. and 3:00 p.m. Copies of the filing also will be available for 23 15 U.S.C. 78s(b)(2)(B). VerDate Mar<15>2010 17:02 Nov 26, 2013 inspection and copying at the principal office of the Exchange. All comments received will be posted without change; the Commission does not edit personal identifying information from submissions. You should submit only information that you wish to make available publicly. All submissions should refer to File Number SR– NASDAQ–2013–140 and should be submitted on or before December 18, 2013. For the Commission, by the Division of Trading and Markets, pursuant to delegated authority.24 Kevin M. O’Neill, Deputy Secretary. [FR Doc. 2013–28420 Filed 11–26–13; 8:45 am] BILLING CODE 8011–01–P SECURITIES AND EXCHANGE COMMISSION [File No. 500–1] Life Stem Genetics Inc.; Order of Suspension of Trading November 25, 2013. It appears to the Securities and Exchange Commission that there is a lack of current and accurate information concerning the securities of Life Stem Genetics Inc. because of questions regarding the accuracy of assertions by the company, and by others, including in press releases to investors concerning, among other things, the company’s operations. The Commission is of the opinion that the public interest and the protection of investors require a suspension of trading in the securities of the above-listed company. Therefore, it is ordered, pursuant to Section 12(k) of the Securities Exchange Act of 1934, that trading in the securities of the above-listed company is suspended for the period from 9:30 a.m. EST, on November 25, 2013 through 11:59 p.m. EST, on December 9, 2013. By the Commission. Jill M. Peterson, Assistant Secretary. [FR Doc. 2013–28607 Filed 11–25–13; 11:15 am] BILLING CODE 8011–01–P 24 17 Jkt 232001 PO 00000 CFR 200.30–3(a)(12). Frm 00107 Fmt 4703 Sfmt 4703 71021 DEPARTMENT OF STATE [Public Notice 8530] Certification Under the Department of State, Foreign Operations, and Related Programs Appropriations Act Certification Pursuant to Section 7041(a) of the Department of State, Foreign Operations, and Related Programs Appropriations Act, 2012 (DIV. I, Pub. L. 112–74) as Carried Forward by the Full Year Continuing Appropriations Act, 2013 (DIV. F, Pub. L. 113–6) By virtue of the authority vested in me as Secretary of State pursuant to section 7041(a) of the Department of State, Foreign Operations, and Related Programs Appropriations Act, 2012 (Div. I, Pub. L. 112–74), as carried forward by the Full Year Continuing Appropriations Act, 2013 (Div. F, Pub. L. 113–6), I hereby certify that the Government of Egypt is meeting its obligations under the 1979 Egypt-Israel Peace Treaty. This determination shall be published in the Federal Register and, along with the accompanying Memorandum of Justification, shall be reported to Congress. Dated: May 3, 2013. John F. Kerry, Secretary of State. Editorial Note: This document arrived at the Federal Register on November 20, 2013. [FR Doc. 2013–28227 Filed 11–26–13; 8:45 am] BILLING CODE 4710–31–P DEPARTMENT OF STATE [Public Notice 8536] Culturally Significant Objects Imported for Exhibition Determinations: ‘‘Antonio Canova: The Seven Last Works’’ Notice is hereby given of the following determinations: Pursuant to the authority vested in me by the Act of October 19, 1965 (79 Stat. 985; 22 U.S.C. 2459), Executive Order 12047 of March 27, 1978, the Foreign Affairs Reform and Restructuring Act of 1998 (112 Stat. 2681, et seq.; 22 U.S.C. 6501 note, et seq.), Delegation of Authority No. 234 of October 1, 1999, Delegation of Authority No. 236–3 of August 28, 2000 (and, as appropriate, Delegation of Authority No. 257 of April 15, 2003), I hereby determine that the objects to be included in the exhibition ‘‘Antonio Canova: The Seven Last Works,’’ imported from abroad for temporary exhibition within the United States, are SUMMARY: E:\FR\FM\27NON1.SGM 27NON1

Agencies

[Federal Register Volume 78, Number 229 (Wednesday, November 27, 2013)]
[Notices]
[Page 71021]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-28607]


-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[File No. 500-1]


Life Stem Genetics Inc.; Order of Suspension of Trading

November 25, 2013.
    It appears to the Securities and Exchange Commission that there is 
a lack of current and accurate information concerning the securities of 
Life Stem Genetics Inc. because of questions regarding the accuracy of 
assertions by the company, and by others, including in press releases 
to investors concerning, among other things, the company's operations.
    The Commission is of the opinion that the public interest and the 
protection of investors require a suspension of trading in the 
securities of the above-listed company.
    Therefore, it is ordered, pursuant to Section 12(k) of the 
Securities Exchange Act of 1934, that trading in the securities of the 
above-listed company is suspended for the period from 9:30 a.m. EST, on 
November 25, 2013 through 11:59 p.m. EST, on December 9, 2013.

    By the Commission.
Jill M. Peterson,
Assistant Secretary.
[FR Doc. 2013-28607 Filed 11-25-13; 11:15 am]
BILLING CODE 8011-01-P